Assessing cardiovascular disease risk in women with a history of hypertensive disorders of pregnancy: A guidance paper for studies using administrative data
- PMID: 38220144
- DOI: 10.1111/ppe.13043
Assessing cardiovascular disease risk in women with a history of hypertensive disorders of pregnancy: A guidance paper for studies using administrative data
Abstract
Background: Hypertensive disorders of pregnancy (HDP) are a major cause of maternal morbidity and mortality, and their association with increased cardiovascular disease (CVD) risk represents a major public health concern. However, assessing CVD risk in women with a history of these conditions presents unique challenges, especially when studies are carried out using routinely collected data.
Objectives: To summarise and describe key challenges related to the design and conduct of administrative studies assessing CVD risk in women with a history of HDP and provide concrete recommendations for addressing them in future research.
Methods: This is a methodological guidance paper.
Results: Several conceptual and methodological factors related to the data-generating mechanism and study conceptualisation, design/data management and analysis, as well as the interpretation and reporting of study findings should be considered and addressed when designing and carrying out administrative studies on this topic. Researchers should develop an a priori conceptual framework within which the research question is articulated, important study variables are identified and their interrelationships are carefully considered.
Conclusions: To advance our understanding of CVD risk in women with a history of HDP, future studies should carefully consider and address the conceptual and methodological considerations outlined in this guidance paper. In highlighting these challenges, and providing specific recommendations for how to address them, our goal is to improve the quality of research carried out on this topic.
Keywords: cardiovascular disease; epidemiology; hypertensive disorders of pregnancy; research methodology; routinely collected health data.
© 2024 The Authors. Paediatric and Perinatal Epidemiology published by John Wiley & Sons Ltd.
Similar articles
-
Modifiable Risk Factors for Cardiovascular Disease among Women with and without a History of Hypertensive Disorders of Pregnancy.Nutrients. 2023 Jan 13;15(2):410. doi: 10.3390/nu15020410. Nutrients. 2023. PMID: 36678281 Free PMC article.
-
Maternal hypertensive disorder of pregnancy and offspring early-onset cardiovascular disease in childhood, adolescence, and young adulthood: A national population-based cohort study.PLoS Med. 2021 Sep 28;18(9):e1003805. doi: 10.1371/journal.pmed.1003805. eCollection 2021 Sep. PLoS Med. 2021. PMID: 34582464 Free PMC article.
-
Heterogeneity in the risk of cardiovascular disease mortality after the hypertensive disorders of pregnancy across mothers' lifetime reproductive history.Paediatr Perinat Epidemiol. 2024 Mar;38(3):230-237. doi: 10.1111/ppe.13059. Epub 2024 Feb 21. Paediatr Perinat Epidemiol. 2024. PMID: 38380741
-
Hypertensive Disorders of Pregnancy and Risk of Cardiovascular Disease-Related Morbidity and Mortality: A Systematic Review and Meta-Analysis.Cardiology. 2020;145(10):633-647. doi: 10.1159/000508036. Epub 2020 Aug 25. Cardiology. 2020. PMID: 32841945
-
[Overview of design and construction of hypertensive disorders of a pregnancy-cohort in Shenzhen].Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Dec 10;44(12):1858-1863. doi: 10.3760/cma.j.cn112338-20230518-00308. Zhonghua Liu Xing Bing Xue Za Zhi. 2023. PMID: 38129139 Review. Chinese.
Cited by
-
Protecting vascular health: the role of flavonoids during pregnancy complications in mitigating the risk of vascular dementia later in life.Inflammopharmacology. 2025 Jun;33(6):2919-2934. doi: 10.1007/s10787-025-01788-w. Epub 2025 Jun 5. Inflammopharmacology. 2025. PMID: 40471470 Review.
-
Risk of Incident Atrial Fibrillation in Women With a History of Hypertensive Disorders of Pregnancy: A Population-Based Retrospective Cohort Study.Circulation. 2025 Feb 18;151(7):460-473. doi: 10.1161/CIRCULATIONAHA.124.072418. Epub 2025 Feb 11. Circulation. 2025. PMID: 39931813 Free PMC article.
-
Lifetime history of hypertensive disorders of pregnancy is associated with shorter sleep duration and more sleep disturbance in midlife: results from the Project Viva women's health cohort.Biol Sex Differ. 2025 Jul 1;16(1):46. doi: 10.1186/s13293-025-00725-4. Biol Sex Differ. 2025. PMID: 40597286 Free PMC article.
-
Early Blood Pressures Warrant Attention in Modern Clinical Data Infrastructure.Hypertension. 2025 May;82(5):772-773. doi: 10.1161/HYPERTENSIONAHA.125.24883. Epub 2025 Apr 16. Hypertension. 2025. PMID: 40238909 No abstract available.
-
Obstetrical complications and chronic health along the life course: What we know, what we don't, and where we go from here?Paediatr Perinat Epidemiol. 2024 Mar;38(3):163-167. doi: 10.1111/ppe.13074. Paediatr Perinat Epidemiol. 2024. PMID: 38536736 Free PMC article. No abstract available.
References
REFERENCES
-
- Anthony J, Damasceno A, Ojjii D. Hypertensive disorders of pregnancy: what the physician needs to know. Cardiovasc J Afr. 2016;27(2):104‐110.
-
- Coutinho T, Lamai O, Nerenberg K. Hypertensive disorders of pregnancy and cardiovascular diseases: current knowledge and future directions. Curr Treat Options Cardiovasc Med. 2018;20(7):56.
-
- Wu R, Wang T, Gu R, et al. Hypertensive disorders of pregnancy and risk of cardiovascular disease‐related morbidity and mortality: a systematic review and meta‐analysis. Cardiology. 2020;145(10):633‐647.
-
- Garovic VD, Dechend R, Easterling T, et al. Hypertension in pregnancy: diagnosis, blood pressure goals, and pharmacotherapy: a scientific statement from the American Heart Association. Hypertension. 2022;79(2):e21‐e41.
-
- Bisson C, Dautel S, Patel E, Suresh S, Dauer P, Rana S. Preeclampsia pathophysiology and adverse outcomes during pregnancy and postpartum. Front Med (Lausanne). 2023;10:1144170.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical